Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines

An interventional phase 2 study to evaluate safety and efficacy of AbobotulinumtoxinA treatment for glabellar lines

Inclusion Criteria:

• Moderate to severe glabellar lines at maximum frown as assessed by the Investigator using a photographic scale
• Moderate to severe glabellar lines at maximum frown as assessed by the subject using a static categorical scale

Exclusion Criteria:

• Botulinum toxin treatment in the face within 9 months prior to study treatment